Search results
Shohei Ohtani won't participate in Home Run Derby while rehabbing from Tommy John surgery
Yahoo Sports· 42 minutes agoOhtani, who will turn 30 on Friday, is hitting .320/.402/.646 with 27 home runs and 16 stolen bases...
Wage growth nears three-year low in June as labor market enters 'different regime'
Yahoo Finance· 56 minutes agoOn Wednesday, data from the Department of Labor showed nearly 1.86 million continuing unemployment...
First naval Victoria Cross of First World War could fetch £260,000 at auction
PA Media: UK News via Yahoo News· 1 hour agoMr Ritchie, who was promoted to Captain on the retired list in January 1924, lived at Craig Royston...
5 Stocks to Pop on Fourth of July Celebrations
Zacks via Yahoo News· 2 hours agoThe upcoming Fourth of July celebrations are instilling optimism among investors and strength in the stock market. Industries like transportation,...
Vertex (VRTX) NDA for Vanza Triple Therapy Accepted by FDA
Zacks via Yahoo News· 2 hours agoThe FDA accepts Vertex's (VRTX) new drug application for vanza triple therapy for people living with...
Annovis (ANVS) Up as Its Lead Candidate Meets Goals in PD Study
Zacks via Yahoo News· 2 hours agoAnnovis (ANVS) surges 76% on Jul 2 after meeting the primary and secondary goals with statistical...
OPINION - Joe Biden has presented Democrats with a big lie of his own
Evening Standard via Yahoo News· 2 hours agoThe ridiculous claim that Donald Trump won the 2020 US presidential election was the first big lie...
Ride the Crude Rally With These 3 Promising Energy Stocks
Zacks via Yahoo News· 3 hours agoHigh oil prices favor oil exploration and production activities, increasing the demand for oilfield...
Yahoo Sports AM: The Caitlin Clark Effect
Yahoo Sports· 3 hours ago-round stunners: No. 6 Andrey Rublev lost his Wimbledon opener to No. 122 Francisco Comesaña; No. 6 Markéta Vondroušová, the defending champ, lost her...
Regeneron (REGN), SNY Win EC Approval for Dupixent for COPD
Zacks via Yahoo News· 3 hours agoRegeneron (REGN) and partner Sanofi get approval for their blockbuster drug Dupixent for the chronic...